Kelly Michael Aaron

NeoGenomics, Inc. - Common Stock · Director

Kelly Michael Aaron is listed in public filings as director. This Kelly Michael Aaron insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include NeoGenomics, Inc. - Common Stock (NEO), DMC Global Inc. (BOOM), AMICUS THERAPEUTICS INC (FOLD), and Prime Medicine, Inc. (PRME). Investors use Kelly Michael Aaron's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
NeoGenomics, Inc. - Common StockNEO--23.1k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable23.1k shares----
NeoGenomics, Inc. - Common StockNEO--16k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable16k shares----
NeoGenomics, Inc. - Common StockNEO$116k11.1k sharesGrant / ExerciseJun 1, 2026$116.4K11.1k shares$10.52--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
DMC Global Inc.BOOM--65.6k sharesGrant / ExerciseMay 13, 2026Disclosure amount unavailable16.9k shares----
AMICUS THERAPEUTICS INCFOLD$072.5k sharesOtherApr 27, 2026$1.1M72.5k shares$14.50--
AMICUS THERAPEUTICS INCFOLD$074.9k sharesOtherApr 27, 2026$446.2K74.9k shares$5.96--
AMICUS THERAPEUTICS INCFOLD$042.5k sharesOtherApr 27, 2026$436.1K42.5k shares$10.27--
AMICUS THERAPEUTICS INCFOLD$045.4k sharesOtherApr 27, 2026$388.4K45.4k shares$8.55--
AMICUS THERAPEUTICS INCFOLD$036.1k sharesOtherApr 27, 2026$386.7K36.1k shares$10.71--
AMICUS THERAPEUTICS INCFOLD$030.5k sharesOtherApr 27, 2026$384.6K30.5k shares$12.62--
Prime Medicine, Inc.PRME$039.1k sharesOtherAug 1, 2025$579.3K39.1k shares$14.83--
Prime Medicine, Inc.PRME$045k sharesOtherAug 1, 2025$345.6K45k shares$7.68--
Prime Medicine, Inc.PRME$182k45k sharesGrant / ExerciseAug 1, 2025$181.8K45k shares$4.04--
Prime Medicine, Inc.PRME$158k39.1k sharesGrant / ExerciseAug 1, 2025$157.8K39.1k shares$4.04--
Prime Medicine, Inc.PRME$09k sharesOtherAug 1, 2025$153.1K9k shares$17.00--
Prime Medicine, Inc.PRME$013.5k sharesOtherAug 1, 2025$142.4K13.5k shares$10.54--
Prime Medicine, Inc.PRME$55k13.5k sharesGrant / ExerciseAug 1, 2025$54.6K13.5k shares$4.04--
Prime Medicine, Inc.PRME$36k9k sharesGrant / ExerciseAug 1, 2025$36.4K9k shares$4.04--
AMICUS THERAPEUTICS INCFOLD$446k74.9k sharesGrant / ExerciseJun 5, 2025$446.2K74.9k shares$5.96--
AMICUS THERAPEUTICS INCFOLD--72.5k sharesGrant / ExerciseJun 5, 2025Disclosure amount unavailable20.4k shares----
Prime Medicine, Inc.PRME$73k55k sharesGrant / ExerciseJun 4, 2025$72.6K55k shares$1.32--
NeoGenomics, Inc. - Common StockNEO--12.3k sharesGrant / ExerciseJun 1, 2025Disclosure amount unavailable12.3k shares----
NeoGenomics, Inc. - Common StockNEO--23.1k sharesGrant / ExerciseJun 1, 2025Disclosure amount unavailable23.1k shares----
NeoGenomics, Inc. - Common StockNEO$117k16.1k sharesGrant / ExerciseJun 1, 2025$117.3K16.1k shares$7.28--
NeoGenomics, Inc. - Common StockNEO$38k5k sharesBuyMay 27, 2025$38.0K5k shares$7.60--
DMC Global Inc.BOOM--48.7k sharesGrant / ExerciseMay 14, 2025Disclosure amount unavailable17.6k shares----
DMC Global Inc.BOOM--31.1k sharesGrant / ExerciseFeb 26, 2025Disclosure amount unavailable5.5k shares----
NeoGenomics, Inc. - Common StockNEO--11.3k sharesGrant / ExerciseAug 10, 2024Disclosure amount unavailable11.3k shares----
Prime Medicine, Inc.PRME$346k45k sharesGrant / ExerciseJun 12, 2024$345.6K45k shares$7.68--